• Krishnan Ravindran, Amanda M Casabella, Juan Cebral, Waleed Brinjikji, David F Kallmes, and Ram Kadirvel.
• Department of Radiology, Mayo Clinic, Rochester, Minnesota.
• Neurosurgery. 2020 Jan 1; 86 (Suppl 1): S13S19S13-S19.

AbstractFlow diverters have drastically changed the landscape of intracranial aneurysm treatment and are now considered first-line therapy for select lesions. Their mechanism of action relies on intrinsic alteration in hemodynamic parameters, both at the parent artery and within the aneurysm sac. Moreover, the device struts act as a nidus for endothelial cell growth across the aneurysm neck ultimately leading to aneurysm exclusion from the circulation. In silico computational analyses and investigations in preclinical animal models have provided valuable insights into the underlying biological basis for flow diverter therapy. Here, we review the present understanding pertaining to flow diverter biology and mechanisms of action, focusing on stent design, induction of intra-aneurysmal thrombosis, endothelialization, and alterations in hemodynamics.Copyright © 2019 by the Congress of Neurological Surgeons.

17 keywords...

hide…